-
1
-
-
41349099104
-
Cancer statistics
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer J Clin 58(2):71-96
-
(2008)
CA Cancer J Clin
, vol.58
, Issue.2
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
Thun, M.J.7
-
3
-
-
79956197640
-
HER2-targeted therapies: How far we've come-and where we've headed
-
Davidson NE (2011) HER2-targeted therapies: how far we've come-and where we've headed. Oncology (Williston Park) 25(5):425-426
-
(2011)
Oncology (Williston Park)
, vol.25
, Issue.5
, pp. 425-426
-
-
Davidson, N.E.1
-
4
-
-
0242624620
-
Biologic and therapeutic role of HER2 in cancer
-
Ménard S, Pupa SM, Campiglio M, Tagliabue E (2003) Biologic and therapeutic role of HER2 in cancer. Oncogene 22(42):6570-6578 (Pubitemid 37372337)
-
(2003)
Oncogene
, vol.22
, Issue.43
, pp. 6570-6578
-
-
Menard, S.1
Pupa, S.M.2
Campiglio, M.3
Tagliabue, E.4
-
5
-
-
80052069976
-
HER2 expression in breast cancer cells is downregulated upon active targeting by antibody-engineered multifunctional nanoparticles in mice
-
Corsi F, Fiandra L, De Palma C, Colombo M, Mazzucchelli S, Verderio P, Allevi R, Tosoni A, Nebuloni M, Clementi E, Prosperi D (2011) HER2 expression in breast cancer cells is downregulated upon active targeting by antibody-engineered multifunctional nanoparticles in mice. ACS Nano 5(8):6383-6393
-
(2011)
ACS Nano
, vol.5
, Issue.8
, pp. 6383-6393
-
-
Corsi, F.1
Fiandra, L.2
De Palma, C.3
Colombo, M.4
Mazzucchelli, S.5
Verderio, P.6
Allevi, R.7
Tosoni, A.8
Nebuloni, M.9
Clementi, E.10
Prosperi, D.11
-
6
-
-
0343819997
-
Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas
-
Porebska I, Harlozinska A, Bojarowski T (2000) Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol 21(2):105-115 (Pubitemid 30114656)
-
(2000)
Tumor Biology
, vol.21
, Issue.2
, pp. 105-115
-
-
Porebska, I.1
Harlozinska, A.2
Bojarowski, T.3
-
7
-
-
79956101962
-
The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models
-
LaBonte MJ, Wilson PM, Fazzone W, Russell J, Louie SG, El-Khoueiry A, Lenz HJ, Ladner RD (2011) The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models. Cancer Res 71(10):3635-3648
-
(2011)
Cancer Res
, vol.71
, Issue.10
, pp. 3635-3648
-
-
LaBonte, M.J.1
Wilson, P.M.2
Fazzone, W.3
Russell, J.4
Louie, S.G.5
El-Khoueiry, A.6
Lenz, H.J.7
Ladner, R.D.8
-
8
-
-
0034002793
-
Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology
-
DOI 10.1016/S0899-9007(99)00266-X, PII S089990079900266X
-
Kuhajda FP (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16(3):202-208 (Pubitemid 30114274)
-
(2000)
Nutrition
, vol.16
, Issue.3
, pp. 202-208
-
-
Kuhajda, F.P.1
-
9
-
-
0024315871
-
Fatty acid synthase, a proficient multifunctional enzyme
-
DOI 10.1021/bi00437a001
-
Wakil SJ (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28(11):4523-4530 (Pubitemid 19151020)
-
(1989)
Biochemistry
, vol.28
, Issue.11
, pp. 4523-4530
-
-
Wakil, S.J.1
-
10
-
-
33644697200
-
Architecture of mammalian fatty acid synthase at 4.5 à resolution
-
DOI 10.1126/science.1123248
-
Maier T, Jenni S, Ban N (2006) Architecture of mammalian fatty acid synthase at 4.5 A resolution. Science 311(5765):1258-1262 (Pubitemid 43334709)
-
(2006)
Science
, vol.311
, Issue.5765
, pp. 1258-1262
-
-
Maier, T.1
Jenni, S.2
Ban, N.3
-
11
-
-
33745728461
-
Fatty acid synthase and cancer: New application of an old pathway
-
Kuhajda FP (2006) Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 66(12):5977-5980
-
(2006)
Cancer Res
, vol.66
, Issue.12
, pp. 5977-5980
-
-
Kuhajda, F.P.1
-
12
-
-
0033996516
-
Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells
-
Huang PL, Zhu SN, Lu SL, Dai ZS, Jin YL (2000) Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J Gastroenterol 6(2):295-297 (Pubitemid 30223620)
-
(2000)
World Journal of Gastroenterology
, vol.6
, Issue.2
, pp. 295-297
-
-
Huang, P.L.1
Zhu, S.N.2
Lu, S.L.3
Dai, Z.S.4
Jin, Y.L.5
-
13
-
-
70349649506
-
EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells
-
Huang CH, Tsai SJ, Wang YJ, Pan MH, Kao JY, Way TD (2009) EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol Nutr Food Res 53(9):1156-1165
-
(2009)
Mol Nutr Food Res
, vol.53
, Issue.9
, pp. 1156-1165
-
-
Huang, C.H.1
Tsai, S.J.2
Wang, Y.J.3
Pan, M.H.4
Kao, J.Y.5
Way, T.D.6
-
14
-
-
0037226462
-
Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis
-
Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63(1):132-139 (Pubitemid 36070431)
-
(2003)
Cancer Research
, vol.63
, Issue.1
, pp. 132-139
-
-
Kumar-Sinha, C.1
Ignatoski, K.W.2
Lippman, M.E.3
Ethier, S.P.4
Chinnaiyan, A.M.5
-
15
-
-
7244252915
-
Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation
-
DOI 10.1002/mc.20054
-
Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R (2004) Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Mol Carcinog 41(3):164-178 (Pubitemid 39435113)
-
(2004)
Molecular Carcinogenesis
, vol.41
, Issue.3
, pp. 164-178
-
-
Menendez, J.A.1
Mehmi, I.2
Verma, V.A.3
Teng, P.K.4
Lupu, R.5
-
16
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method
-
DOI 10.1006/meth.2001.1262
-
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 25(4):402-408 (Pubitemid 34164012)
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
17
-
-
38549147538
-
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
-
DOI 10.1111/j.1365-2184.2007.00498.x
-
Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA (2008) Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 41(1):59-85 (Pubitemid 351147647)
-
(2008)
Cell Proliferation
, vol.41
, Issue.1
, pp. 59-85
-
-
Vazquez-Martin, A.1
Colomer, R.2
Brunet, J.3
Lupu, R.4
Menendez, J.A.5
-
18
-
-
63649099458
-
Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer
-
Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E, Fiore C, Xie W, Kung AL, Febbo PG, Subramanian A, Mucci L, Ma J, Signoretti S, Stampfer M, Hahn WC, Finn S, Loda M (2009) Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101(7):519-532
-
(2009)
J Natl Cancer Inst
, vol.101
, Issue.7
, pp. 519-532
-
-
Migita, T.1
Ruiz, S.2
Fornari, A.3
Fiorentino, M.4
Priolo, C.5
Zadra, G.6
Inazuka, F.7
Grisanzio, C.8
Palescandolo, E.9
Shin, E.10
Fiore, C.11
Xie, W.12
Kung, A.L.13
Febbo, P.G.14
Subramanian, A.15
Mucci, L.16
Ma, J.17
Signoretti, S.18
Stampfer, M.19
Hahn, W.C.20
Finn, S.21
Loda, M.22
more..
-
19
-
-
30444434391
-
Targeting fatty acid synthase: Potential for therapeutic intervention in Her-2/neu-overexpressing breast cancer
-
DOI 10.1358/dnp.2005.18.6.927929
-
Menendez JA, Lupu R, Colomer R (2005) Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neuoverexpressing breast cancer. Drug News Perspect 18(6):375-385 (Pubitemid 43073871)
-
(2005)
Drug News and Perspectives
, vol.18
, Issue.6
, pp. 375-385
-
-
Menendez, J.A.1
Lupu, R.2
Colomer, R.3
-
20
-
-
36849074161
-
Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation
-
Chiang CT, Way TD, Tsai SJ, Lin JK (2007) Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Lett 581(30):5735-5742
-
(2007)
FEBS Lett
, vol.581
, Issue.30
, pp. 5735-5742
-
-
Chiang, C.T.1
Way, T.D.2
Tsai, S.J.3
Lin, J.K.4
-
21
-
-
67349136348
-
Interaction between fatty acid synthase-and ErbB-systems in ovarian cancer cells
-
Grunt TW, Wagner R, Grusch M, Berger W, Singer CF, Marian B, Zielinski CC, Lupu R (2009) Interaction between fatty acid synthase-and ErbB-systems in ovarian cancer cells. Biochem Biophys Res Commun 385(3):454-459
-
(2009)
Biochem Biophys Res Commun
, vol.385
, Issue.3
, pp. 454-459
-
-
Grunt, T.W.1
Wagner, R.2
Grusch, M.3
Berger, W.4
Singer, C.F.5
Marian, B.6
Zielinski, C.C.7
Lupu, R.8
-
22
-
-
46649083578
-
Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells
-
Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M, Hayakawa M (2008) Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells. J Urol 180(2):729-736
-
(2008)
J Urol
, vol.180
, Issue.2
, pp. 729-736
-
-
Horiguchi, A.1
Asano, T.2
Asano, T.3
Ito, K.4
Sumitomo, M.5
Hayakawa, M.6
-
23
-
-
57349175482
-
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
-
Carvalho MA, Zecchin KG, Seguin F, Bastos DC, Agostini M, Rangel AL, Veiga SS, Raposo HF, Oliveira HC, Loda M, Coletta RD, Graner E (2008) Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer 123(11):2557-2565
-
(2008)
Int J Cancer
, vol.123
, Issue.11
, pp. 2557-2565
-
-
Carvalho, M.A.1
Zecchin, K.G.2
Seguin, F.3
Bastos, D.C.4
Agostini, M.5
Rangel, A.L.6
Veiga, S.S.7
Raposo, H.F.8
Oliveira, H.C.9
Loda, M.10
Coletta, R.D.11
Graner, E.12
-
24
-
-
39749137454
-
A new mechanism of drug resistance in breast cancer cells: Fatty acid synthase overexpression-mediated palmitate overproduction
-
DOI 10.1158/1535-7163.MCT-07-0445
-
Liu H, Liu Y, Zhang JT (2008) A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther 7(2):263-270 (Pubitemid 351302520)
-
(2008)
Molecular Cancer Therapeutics
, vol.7
, Issue.2
, pp. 263-270
-
-
Liu, H.1
Liu, Y.2
Zhang, J.-T.3
-
26
-
-
33745828702
-
EGF-ERBB signalling: Towards the systems level
-
DOI 10.1038/nrm1962, PII NRM1962
-
Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Natl Rev Mol Cell Biol 7(7):505-516 (Pubitemid 44036456)
-
(2006)
Nature Reviews Molecular Cell Biology
, vol.7
, Issue.7
, pp. 505-516
-
-
Citri, A.1
Yarden, Y.2
-
27
-
-
0033604585
-
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
-
Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253(1):210-229
-
(1999)
Exp Cell Res
, vol.253
, Issue.1
, pp. 210-229
-
-
Kandel, E.S.1
Hay, N.2
-
28
-
-
19944374798
-
Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells
-
DOI 10.1038/sj.onc.1208463
-
Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano A, Testa JR (2005) Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 24(22):3574-3582 (Pubitemid 40756227)
-
(2005)
Oncogene
, vol.24
, Issue.22
, pp. 3574-3582
-
-
Wang, H.Q.1
Altomare, D.A.2
Skele, K.L.3
Poulikakos, P.I.4
Kuhajda, F.P.5
Di Cristofano, A.6
Testa, J.R.7
|